Aequus Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Aequus Pharmaceuticals Inc cash flow-to-debt ratio. Aequus Pharmaceuticals Inc (AQS) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CA$-21.22K could theoretically repay 0% of its total liabilities (CA$7.09 Million) in one year. Check Aequus Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aequus Pharmaceuticals Inc (2013–2024)
Cash flow-to-debt ratio of Aequus Pharmaceuticals Inc from 2013 to 2024. Historical debt coverage capacity for Aequus Pharmaceuticals Inc across 12 annual periods. Check Aequus Pharmaceuticals Inc (AQS) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Aequus Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2013–2024)
Aequus Pharmaceuticals Inc cash flow-to-debt ratio by year from 2013 to 2024. Year-by-year debt coverage analysis for Aequus Pharmaceuticals Inc. For the full cash flow conversion analysis, see Aequus Pharmaceuticals Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.23x | CA$-1.66 Million | CA$7.26 Million | ▲ +46.5% |
| 2023 | -0.43x | CA$-2.29 Million | CA$5.38 Million | ▲ +32.9% |
| 2022 | -0.64x | CA$-1.95 Million | CA$3.07 Million | ▼ -38.8% |
| 2021 | -0.46x | CA$-1.17 Million | CA$2.56 Million | ▼ -45.7% |
| 2020 | -0.31x | CA$-804.91K | CA$2.56 Million | ▲ +50.8% |
| 2019 | -0.64x | CA$-1.63 Million | CA$2.55 Million | ▲ +92.2% |
| 2018 | -8.17x | CA$-2.57 Million | CA$314.90K | ▲ +21.3% |
| 2017 | -10.39x | CA$-3.81 Million | CA$366.84K | ▼ -73.2% |
| 2016 | -6.00x | CA$-4.47 Million | CA$744.41K | ▼ -78.9% |
| 2015 | -3.35x | CA$-3.84 Million | CA$1.15 Million | ▼ -82.9% |
| 2014 | -1.83x | CA$-1.36 Million | CA$744.51K | ▲ +88.1% |
| 2013 | -15.44x | CA$-876.06K | CA$56.74K | — |